LL-37 Protocol
Dosing & Research
Last Updated: April 22, 2026
Antimicrobial defense research, Wound repair, Biofilm and immune-signaling studies, Inflammation modulation
Half-Life
~30 Minutes (plasma)
Administration
• Topical
• Injection
Frequency
Daily To Twice Weekly Based On Wound Type
How It Works
- Antimicrobial defense research
- Wound repair
- Biofilm and immune-signaling studies
- Inflammation modulation
Dosing Structure
Dose
0.5–1.6 mg/mL
Frequency
Daily To Twice Weekly Based On Wound Type
Notes
Continue Until Complete Healing Achieved.
Example Protocols
Dose: 0.5–1.6 mg/mL
Frequency: Daily To Twice Weekly Based On Wound Type
Duration: 2-8 weeks depending on healing progress
Off Period: Not listed
Protocol Notes
•
Continue until complete healing achieved.
Research & Studies
Loading citations…
Research Feedback
0 approved
For research discussion only. Community feedback is moderated and shown here as aggregated insights after approval.
Be the first to submit research feedback for this peptide.
Approved submissions will appear here as aggregated insights.